Market Cap

$8.4B

Volume

6.2M

Cash and Equivalents

$2.0B

EBITDA

-$1.1B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

-$423.1M

Profit Margin

-327.64%

52 Week High

$13.05

52 Week Low

$9.69

Dividend

N/A

Price / Book Value

1.64

Price / Earnings

2.05

Price / Tangible Book Value

1.64

Enterprise Value

$3.5B

Enterprise Value / EBITDA

-3.13

Operating Income

-$1.1B

Return on Equity

128.96%

Return on Assets

-17.24

Cash and Short Term Investments

$5.4B

Debt

$52.7M

Equity

$5.6B

Revenue

$129.1M

Unlevered FCF

-$401.4M

Sector

Biotechnology

Category

N/A